Gencurix Inc (229000) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.094x

Based on the latest financial reports, Gencurix Inc (229000) has a cash flow conversion efficiency ratio of -0.094x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.31 Billion ≈ $-891.09K USD) by net assets (₩13.99 Billion ≈ $9.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Gencurix Inc worth for the company's overall valuation and market capitalisation.

Gencurix Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Gencurix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Gencurix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gencurix Inc ranked by their cash flow conversion efficiency. Explore 229000 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Genoway PA:ALGEN	-0.152x
CTK Co. Ltd KQ:260930	-0.017x
Youlife Group Inc. American Depositary Shares NASDAQ:YOUL	N/A
Battalion Oil Corp NYSE MKT:BATL	-1.381x
TINYBUILD REGSCAT3 DL-001 F:8Z3	N/A
Kiattana Transport Public Company Limited BK:KIAT	0.045x
Wiseway Group Ltd AU:WWG	0.102x
Midland Exploration Inc V:MD	-0.018x

Annual Cash Flow Conversion Efficiency for Gencurix Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Gencurix Inc from 2016 to 2025. View latest Gencurix Inc stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩16.37 Billion ≈ $11.09 Million	₩-6.24 Billion ≈ $-4.23 Million	-0.381x	+20.79%
2024-12-31	₩14.90 Billion ≈ $10.10 Million	₩-7.17 Billion ≈ $-4.86 Million	-0.481x	+46.80%
2023-12-31	₩12.00 Billion ≈ $8.13 Million	₩-10.86 Billion ≈ $-7.36 Million	-0.905x	+43.94%
2022-12-31	₩6.48 Billion ≈ $4.39 Million	₩-10.45 Billion ≈ $-7.08 Million	-1.614x	-497.94%
2021-12-31	₩30.99 Billion ≈ $21.00 Million	₩-8.37 Billion ≈ $-5.67 Million	-0.270x	-6.05%
2020-12-31	₩53.38 Billion ≈ $36.17 Million	₩-13.59 Billion ≈ $-9.21 Million	-0.255x	+99.24%
2019-12-31	₩155.18 Million ≈ $105.16K	₩-5.22 Billion ≈ $-3.54 Million	-33.651x	-6050.17%
2018-12-31	₩9.20 Billion ≈ $6.23 Million	₩-5.03 Billion ≈ $-3.41 Million	-0.547x	+35.20%
2017-12-31	₩6.41 Billion ≈ $4.34 Million	₩-5.41 Billion ≈ $-3.67 Million	-0.844x	-15.80%
2016-12-31	₩8.20 Billion ≈ $5.56 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.729x	--

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$31.07 Million

₩45.85 Billion KRW

Market Cap Rank

#23735 Global

#1639 in Korea

Share Price

₩1957.00

Change (1 day)

+0.88%

52-Week Range

₩1400.00 - ₩5870.00

All Time High

₩23845.65